{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:24:05Z","timestamp":1787009045631,"version":"build-2736575974"},"reference-count":109,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T00:00:00Z","timestamp":1779321600000},"content-version":"vor","delay-in-days":21,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"internal funding"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,4,30]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Antimicrobial resistance (AMR) is a serious and growing public health concern driven by multiple factors. Urinary tract infection (UTI) is one of the infections commonly associated with AMR, and more than 80% of UTIs are caused by Escherichia coli. MDR E. coli is a significant problem that requires urgent intervention, particularly in complicated UTIs (cUTIs) with underlying comorbidities. Although prevalence rates of MDR E. coli vary globally, it remains a critical clinical and economic challenge on every continent. The majority of MDR E. coli strains produce ESBLs, followed by AmpC enzymes, making them generally resistant to penicillins, cephalosporins and aztreonam. While there are some therapeutic options for uncomplicated UTIs (uUTIs), choices are limited for cUTIs, with carbapenems being the mainstay of treatment. However, carbapenem resistance is on the rise, severely impeding clinical regimens. With very few options available, combinations of antimicrobial agents for synergistic activity are increasingly relied upon for carbapenem-resistant E. coli. This situation has compelled the search for novel antimicrobial agents, which are slowly entering the market, although not as quickly as AMR is spreading worldwide. Current focus is shifting towards alternative antimicrobial therapies that exhibit broad-spectrum bactericidal activity and immunomodulatory effects, considered for both preventive and therapeutic strategies. A multi-disciplinary approach combining novel antimicrobials, innovative therapies and robust infection control measures will be essential to effectively manage MDR E. coli in uUTIs and cUTIs and mitigate the global threat of antibiotic resistance.<\/jats:p>","DOI":"10.1093\/jacamr\/dlag081","type":"journal-article","created":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T12:12:18Z","timestamp":1777637538000},"source":"Crossref","is-referenced-by-count":1,"title":["Therapeutic strategies for multi-resistant\n                    <i>Escherichia coli<\/i>\n                    in urinary tract infections\u2014a cause for concern"],"prefix":"10.1093","volume":"8","author":[{"given":"Rekha","family":"Unni","sequence":"first","affiliation":[{"name":"Post Graduate and Research Department of Chemistry, Christian College, University of Kerala , Chengannur, Kerala 689122 ,","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruby","family":"Varghese","sequence":"additional","affiliation":[{"name":"Department of Chemistry and Biochemistry, School of Sciences, Jain Deemed to be University , Bengaluru, Karnataka 560027 ,","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benita","family":"Arakal","sequence":"additional","affiliation":[{"name":"School of Sports and Health Sciences, Cardiff Metropolitan University , Llandaff Campus, Cardiff CF5 2YB ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lochana","family":"Padmanabhan","sequence":"additional","affiliation":[{"name":"Department of Chemistry and Biochemistry, School of Sciences, Jain Deemed to be University , Bengaluru, Karnataka 560027 ,","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srijita","family":"Karmakar","sequence":"additional","affiliation":[{"name":"Department of Chemistry and Biochemistry, School of Sciences, Jain Deemed to be University , Bengaluru, Karnataka 560027 ,","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Achinthya","family":"Sampathila","sequence":"additional","affiliation":[{"name":"Department of Chemistry and Biochemistry, School of Sciences, Jain Deemed to be University , Bengaluru, Karnataka 560027 ,","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yogesh Bharat","family":"Dalvi","sequence":"additional","affiliation":[{"name":"Pushpagiri Institute of Medical Sciences, Pushpagiri Research Center , Thiruvalla, Kerala 689101 ,","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1694-305X","authenticated-orcid":false,"given":"Paul","family":"Livingstone","sequence":"additional","affiliation":[{"name":"School of Sports and Health Sciences, Cardiff Metropolitan University , Llandaff Campus, Cardiff CF5 2YB ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,5,21]]},"reference":[{"key":"2026060405421984900_dlag081-B1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/diagnostics13223421","article-title":"Assessment of UTI diagnostic techniques using the fuzzy\u2013PROMETHEE model","volume":"13","author":"Abobakr","year":"2023","journal-title":"Diagnostics"},{"key":"2026060405421984900_dlag081-B2","article-title":"Clinical practice guideline by Infectious Diseases Society of America (IDSA): 2025 guideline on management and treatment of complicated urinary tract infections: introduction and methods","author":"Trautner","year":"2025","journal-title":"Clin Infect Dis"},{"key":"2026060405421984900_dlag081-B3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7759\/cureus.35140","article-title":"Isolation of Staphylococcus aureus urinary tract infections at a community-based healthcare center in Riyadh","volume":"15","author":"Alshomrani","year":"2023","journal-title":"Cureus"},{"key":"2026060405421984900_dlag081-B4","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The third international consensus definitions for sepsis and septic shock (Sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA"},{"key":"2026060405421984900_dlag081-B5","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1093\/cid\/ciw396","article-title":"Clinical management of an increasing threat: outpatient urinary tract infections due to multidrug-resistant uropathogens","volume":"63","author":"Walker","year":"2016","journal-title":"Clin Infect Dis"},{"key":"2026060405421984900_dlag081-B6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/cid\/ciae403","article-title":"Infectious Diseases Society of America 2024 guidance on the treatment of antimicrobial-resistant gram-negative infections","volume":"10","author":"Tamma","year":"2024","journal-title":"Clin Infect Dis"},{"key":"2026060405421984900_dlag081-B7","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1038\/s41585-024-00877-9","article-title":"Current and emerging strategies to curb antibiotic-resistant urinary tract infections","volume":"21","author":"Simoni","year":"2024","journal-title":"Nat Rev Urol"},{"key":"2026060405421984900_dlag081-B8","doi-asserted-by":"publisher","first-page":"25","DOI":"10.4103\/0974-7796.106962","article-title":"Do we really know the prevalence of multi-drug resistant Escherichia coli in the territorial and nosocomial population?","volume":"5","author":"Picozzi","year":"2013","journal-title":"Urol Ann"},{"key":"2026060405421984900_dlag081-B9","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1586\/14787210.2015.1028365","article-title":"Multidrug-resistant Escherichia coli in Asia: epidemiology and management","volume":"13","author":"Sidjabat","year":"2015","journal-title":"Expert Rev Anti Infect Ther"},{"key":"2026060405421984900_dlag081-B10","doi-asserted-by":"publisher","first-page":"5","DOI":"10.7759\/cureus.63663","article-title":"Investigating urinary pathogens and their antibiotic resistance: a cross-sectional urine culture study","volume":"16","author":"Khan","year":"2024","journal-title":"Cureus"},{"key":"2026060405421984900_dlag081-B11","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1186\/s12879-025-10635-w","article-title":"Analysis of phylogroups, biofilm formation, virulence factors, antibiotic resistance and molecular typing of uropathogenic Escherichia coli strains isolated from patients with recurrent and non-recurrent urinary tract infections","volume":"25","author":"Mahshouri","year":"2025","journal-title":"BMC Infect Dis"},{"key":"2026060405421984900_dlag081-B12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0274423","article-title":"Prevalence, etiology and antibiotic resistance patterns of community-acquired urinary tract infections in Dhaka, Bangladesh","volume":"17","author":"Islam","year":"2022","journal-title":"PLoS One"},{"key":"2026060405421984900_dlag081-B13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0305431","article-title":"Colistin-resistance genes in Escherichia coli isolated from patients with urinary tract infections","volume":"19","author":"Al Momani","year":"2024","journal-title":"PLoS One"},{"key":"2026060405421984900_dlag081-B14","doi-asserted-by":"publisher","first-page":"7278070","DOI":"10.1155\/2023\/7278070","article-title":"Virulence factors and antimicrobial resistance of uropathogenic Escherichia coli EQ101 UPEC isolated from UTI patient in Quetta, Balochistan, Pakistan","volume":"2023","author":"Fatima","year":"2023","journal-title":"Biomed Res Int"},{"key":"2026060405421984900_dlag081-B15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0201613","article-title":"Genomic characterization of NDM-1 and 5, and OXA-181 carbapenemases in uropathogenic Escherichia coli isolates from Riyadh, Saudi Arabia","volume":"13","author":"El Ghany","year":"2018","journal-title":"PLoS One"},{"key":"2026060405421984900_dlag081-B16","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1089\/mdr.2022.0003","article-title":"Antimicrobial resistance genes, virulence genes, and associated Mobile genetic elements of eight multidrug-resistant enterobacterales isolated from hospital-acquired urinary tract infections in Sri Lanka","volume":"28","author":"Perera","year":"2022","journal-title":"Microb Drug Resist"},{"key":"2026060405421984900_dlag081-B17","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.jgar.2019.07.029","article-title":"High prevalence of carbapenemase, AmpC \u03b2-lactamase and aminoglycoside resistance genes in extended-spectrum \u03b2-lactamase-positive uropathogens from Northern India","volume":"20","author":"Gajamer","year":"2020","journal-title":"J Glob Antimicrob Resist"},{"key":"2026060405421984900_dlag081-B18","doi-asserted-by":"publisher","first-page":"659","DOI":"10.3390\/pathogens11060659","article-title":"Worldwide prevalence of mcr-mediated colistin-resistance Escherichia coli in isolates of clinical samples, healthy humans, and livestock\u2014a systematic review and meta-analysis","volume":"11","author":"Bastidas-Caldes","year":"2022","journal-title":"Pathogens"},{"key":"2026060405421984900_dlag081-B19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4102\/ajlm.v11i1.1594","article-title":"Global antimicrobial resistance and use surveillance system on the African continent: early implementation 2017\u20132019","volume":"11","author":"Tornimbene","year":"2022","journal-title":"Afr J Lab Med"},{"key":"2026060405421984900_dlag081-B20","doi-asserted-by":"publisher","first-page":"35","DOI":"10.4103\/njcp.njcp_299_23","article-title":"Etiologic and anti-microbial susceptibility profiles of bacterial urinary tract infection and bacterial enteritis among children at a private multi-specialty healthcare facility in Abuja, Nigeria: a 5-year separate and comparative review","volume":"27","author":"Adeleye","year":"2024","journal-title":"Niger J Clin Pract"},{"key":"2026060405421984900_dlag081-B21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12879-024-09086-6","article-title":"Trends and predictors of antimicrobial resistance among patients with urinary tract infections at a tertiary hospital facility in Alexandria, Egypt: a retrospective record-based classification and regression tree analysis","volume":"24","author":"Shaker","year":"2024","journal-title":"BMC Infect Dis"},{"key":"2026060405421984900_dlag081-B22","doi-asserted-by":"publisher","DOI":"10.1093\/jacamr\/dlae019","article-title":"Predominance of multidrug-resistant bacteria causing urinary tract infections among symptomatic patients in East Africa: a call for action","volume":"6","author":"Maldonado-Barrag\u00e1n","year":"2024","journal-title":"JAC Antimicrob Resist"},{"key":"2026060405421984900_dlag081-B23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fpubh.2023.1187934","article-title":"Phenotypic characterization and epidemiology of extended-spectrum \u03b2-lactamase-producing Enterobacteriaceae strains from urinary tract infections in Garoua, Cameroon","volume":"11","author":"Djim-Adjim-Ngana","year":"2023","journal-title":"Front Public Heal"},{"key":"2026060405421984900_dlag081-B24","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.eururo.2024.03.035","article-title":"EAU guidelines on urological infections","volume":"10","author":"Bonkat","year":"2024","journal-title":"Eur Assoc Urol"},{"key":"2026060405421984900_dlag081-B25","doi-asserted-by":"crossref","unstructured":"Al-Mustapha AI, Muasa B, Adetunji V \u00a0et al \u00a0Global distribution and incidence of multidrug resistant and ESBL producing Escherichia coli: an observational study of the ATLAS dataset. Clin Epidemiol Glob Health \u00a02025; 35: 102150. 10.1016\/j.cegh.2025.102150","DOI":"10.1016\/j.cegh.2025.102150"},{"key":"2026060405421984900_dlag081-B26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2807\/1560-7917.ES.2023.28.43.2200934","article-title":"Increasing proportions of extended-spectrum \u03b2-lactamase-producing isolates among Escherichia coli from urine and bloodstream infections: results from a nationwide surveillance network, Finland, 2008 to 2019","volume":"28","author":"Ilmavirta","year":"2023","journal-title":"Euro Surveill"},{"key":"2026060405421984900_dlag081-B27","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.jgar.2018.11.004","article-title":"Antimicrobial resistance of Escherichia coli isolates from outpatient urinary tract infections in women in six European countries including Russia","volume":"17","author":"Ny","year":"2019","journal-title":"J Glob Antimicrob Resist"},{"key":"2026060405421984900_dlag081-B28","doi-asserted-by":"publisher","first-page":"2028","DOI":"10.1093\/jac\/dkad201","article-title":"Uropathogenic Escherichia coli population structure and antimicrobial susceptibility in Norfolk, UK","volume":"78","author":"Carter","year":"2023","journal-title":"J Antimicrob Chemother"},{"key":"2026060405421984900_dlag081-B29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/jacamr\/dlad122","article-title":"Nitrofurantoin resistance as an indicator for multidrug resistance: an assessment of Escherichia coli urinary tract specimens in England, 2015\u201319","volume":"5","author":"Guy","year":"2023","journal-title":"JAC Antimicrob Resist"},{"key":"2026060405421984900_dlag081-B30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/antibiotics11050548","article-title":"What doesn\u2019t kill them makes them stronger: the impact of the resistance patterns of urinary enterobacterales isolates in patients from a tertiary hospital in Eastern Europe","volume":"11","author":"Miftode","year":"2022","journal-title":"Antibiotics"},{"key":"2026060405421984900_dlag081-B31","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1111\/ggi.14080","article-title":"Characteristics of urinary tract infections in older patients in a tertiary hospital in Greece","volume":"20","author":"Ioannou","year":"2020","journal-title":"Geriatr Gerontol Int"},{"key":"2026060405421984900_dlag081-B32","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.jgar.2019.06.016","article-title":"Antibiotic treatment and antimicrobial resistance in children with urinary tract infections","volume":"20","author":"Vazouras","year":"2020","journal-title":"J Glob Antimicrob Resist"},{"key":"2026060405421984900_dlag081-B33","doi-asserted-by":"publisher","first-page":"ofaf610","DOI":"10.1093\/ofid\/ofaf610","article-title":"Snapshot genomic surveillance reveals insights into antimicrobial resistance and lineage diversity of uropathogens in older adults in Queensland","volume":"12","author":"Permana","year":"2025","journal-title":"Open Forum Infect Dis"},{"key":"2026060405421984900_dlag081-B34","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0026578","article-title":"Insights into a multidrug resistant Escherichia coli pathogen of the globally disseminated ST131 lineage: genome analysis and virulence mechanisms","volume":"6","author":"Totsika","year":"2011","journal-title":"PLoS One"},{"key":"2026060405421984900_dlag081-B35","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1128\/AAC.02052-13","article-title":"Community-onset Escherichia coli infection resistant to expanded-spectrum cephalosporins in low-prevalence countries","volume":"58","author":"Rogers","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"2026060405421984900_dlag081-B36","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1186\/s12894-024-01654-x","article-title":"Multidrug resistance in urinary E. coli higher in males compared to females","volume":"24","author":"Khanal","year":"2024","journal-title":"BMC Urol"},{"key":"2026060405421984900_dlag081-B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanwpc.2024.101036","article-title":"The changing epidemiology of antimicrobial resistance in Fiji: a descriptive analysis of antimicrobial susceptibility and trends of endemic and emerging pathogens, 2019\u20132022","volume":"45","author":"Getahun Strobel","year":"2024","journal-title":"Lancet Reg Health West Pac"},{"key":"2026060405421984900_dlag081-B38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/antibiotics8010029","article-title":"Antibiotic resistance in Pacific island countries and territories: a systematic scoping review","volume":"8","author":"Foxlee","year":"2019","journal-title":"Antibiotics"},{"key":"2026060405421984900_dlag081-B39","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofad287","article-title":"Multidrug resistance of Escherichia coli from outpatient uncomplicated urinary tract infections in a large United States integrated healthcare organization","volume":"10","author":"Ku","year":"2023","journal-title":"Open Forum Infect Dis"},{"key":"2026060405421984900_dlag081-B40","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1093\/jac\/dkae004","article-title":"Determining a urinary-specific antibiogram and risk factors of trimethoprim\/sulfamethoxazole, ciprofloxacin and multidrug resistance among enterobacterales in primary care","volume":"79","author":"Valentine-King","year":"2024","journal-title":"J Antimicrob Chemother"},{"key":"2026060405421984900_dlag081-B41","doi-asserted-by":"publisher","first-page":"5909","DOI":"10.3390\/cimb46060353","article-title":"Uropathogenic E. coli and hybrid pathotypes in Mexican women with urinary tract infections: a comprehensive molecular and phenotypic overview","volume":"46","author":"Ballesteros-Monrreal","year":"2024","journal-title":"Curr Issues Mol Biol"},{"key":"2026060405421984900_dlag081-B42","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.3390\/pathogens13121068","article-title":"Antimicrobial susceptibility trends in E. coli causing pediatric urinary tract infections in the United States","volume":"13","author":"Mahajan","year":"2024","journal-title":"Pathogens"},{"key":"2026060405421984900_dlag081-B43","doi-asserted-by":"publisher","first-page":"14","DOI":"10.18773\/austprescr.2019.002","article-title":"Nitrofurantoin and fosfomycin for resistant urinary tract infections: old drugs for emerging problems","volume":"42","author":"Gardiner","year":"2019","journal-title":"Aust Prescr"},{"key":"2026060405421984900_dlag081-B44","doi-asserted-by":"publisher","first-page":"79","DOI":"10.2174\/1874279301810010079","article-title":"Antimicrobial resistance of uropathogenic Escherichia coli from elderly patients at a general hospital, Argentina","volume":"10","author":"Delpech","year":"2018","journal-title":"Open Infect Dis J"},{"key":"2026060405421984900_dlag081-B45","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1590\/S1678-9946201658002","article-title":"Antibiotic resistance patterns of urinary tract infections in a northeastern Brazilian capital","volume":"58","author":"Cunha","year":"2016","journal-title":"Rev Inst Med Trop Sao Paulo"},{"key":"2026060405421984900_dlag081-B46","doi-asserted-by":"publisher","first-page":"485","DOI":"10.3390\/antibiotics10050485","article-title":"Antimicrobial resistance patterns and dynamics of extended-spectrum \u03b2-lactamase-producing uropathogenic Escherichia coli in Cusco, Peru","volume":"10","author":"Loyola","year":"2021","journal-title":"Antibiotics"},{"key":"2026060405421984900_dlag081-B47","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s13204-011-0031-2","article-title":"Antibacterial potential of silver nanoparticles against isolated urinary tract infectious bacterial pathogens","volume":"1","author":"Jacob Inbaneson","year":"2011","journal-title":"Appl Nanosci"},{"key":"2026060405421984900_dlag081-B48","doi-asserted-by":"publisher","first-page":"214","DOI":"10.3390\/medicina60020214","article-title":"Carbapenem-resistant Enterobacteriaceae in urinary tract infections: from biological insights to emerging therapeutic alternatives","volume":"60","author":"Bologna","year":"2024","journal-title":"Med"},{"key":"2026060405421984900_dlag081-B49","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1111\/j.1365-2672.1992.tb05007.x","article-title":"Antibacterial spectrum of lactoferricin B, a potent bactericidal peptide derived from the N-terminal region of bovine lactoferrin","volume":"73","author":"Bellamy","year":"1992","journal-title":"J Appl Bacteriol"},{"key":"2026060405421984900_dlag081-B50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/molecules25235593","article-title":"Promising roles of alternative medicine and plant-based nanotechnology as remedies for urinary tract infections","volume":"25","author":"Chandra","year":"2020","journal-title":"Molecules"},{"key":"2026060405421984900_dlag081-B51","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.3201\/eid2012.140331","article-title":"Effects of knowledge, attitudes, and practices of primary care providers on antibiotic selection, United States","volume":"20","author":"Sanchez","year":"2014","journal-title":"Emerg Infect Dis"},{"key":"2026060405421984900_dlag081-B52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.26508\/lsa.202301964","article-title":"SLIT2\/ROBO1 signalling suppresses mTORC1 for organelle control and bacterial killing","volume":"6","author":"Bhosle","year":"2023","journal-title":"Life Sci Alliance"},{"key":"2026060405421984900_dlag081-B53","first-page":"9","article-title":"Origins and evolution of antibiotic resistance","volume":"12","author":"Davies","year":"1996","journal-title":"Microbiologia"},{"key":"2026060405421984900_dlag081-B54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12879-016-1888-1","article-title":"Oral fosfomycin for treatment of urinary tract infection: a retrospective cohort study","volume":"16","author":"Matthews","year":"2016","journal-title":"BMC Infect Dis"},{"key":"2026060405421984900_dlag081-B55","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1093\/jac\/dku465","article-title":"Temocillin (6 g daily) in critically ill patients: continuous infusion versus three times daily administration","volume":"70","author":"Laterre","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"2026060405421984900_dlag081-B56","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2021-049481","article-title":"Temocillin versus meropenem for the targeted treatment of bacteraemia due to third-generation cephalosporin-resistant enterobacterales (ASTART\u00c9): protocol for a randomised, pragmatic trial","volume":"11","author":"Mar\u00edn-Cand\u00f3n","year":"2021","journal-title":"BMJ Open"},{"key":"2026060405421984900_dlag081-B57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/antibiotics9080511","article-title":"Effective treatment for uncomplicated urinary tract infections with oral fosfomycin, single center four year retrospective study","volume":"9","author":"Fajfr","year":"2020","journal-title":"Antibiotics"},{"key":"2026060405421984900_dlag081-B58","doi-asserted-by":"publisher","first-page":"466","DOI":"10.53854\/liim-3104-5","article-title":"Worldwide prevalence of extended-spectrum \u03b2-lactamases-producing uropathogenic Escherichia coli isolates among kidney transplant patients: a systematic review and meta-analysis","volume":"31","author":"Mostaghimi","year":"2023","journal-title":"Infez Med"},{"key":"2026060405421984900_dlag081-B59","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.jgar.2021.09.013","article-title":"Novel \u03b2-lactam\/\u03b2-lactamase inhibitor combinations versus alternative antibiotics in adults with hospital-acquired pneumonia or ventilator-associated pneumonia: an integrated analysis of three randomised controlled trials","volume":"29","author":"Zhuang","year":"2022","journal-title":"J Glob Antimicrob Resist"},{"key":"2026060405421984900_dlag081-B60","doi-asserted-by":"publisher","first-page":"133","DOI":"10.18773\/austprescr.2025.038","article-title":"Aminoglycosides: an update on indications, dosing and monitoring","volume":"48","author":"Moore","year":"2025","journal-title":"Aust Prescr"},{"key":"2026060405421984900_dlag081-B61","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1038\/s41585-020-0362-4","article-title":"Epidemiology, definition and treatment of complicated urinary tract infections","volume":"17","author":"Wagenlehner","year":"2020","journal-title":"Nat Rev Urol"},{"key":"2026060405421984900_dlag081-B62","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1039\/C8MD00342D","article-title":"\u0392-lactam\/\u0392-lactamase inhibitor combinations: an update","volume":"9","author":"Tehrani","year":"2018","journal-title":"MedChemComm"},{"key":"2026060405421984900_dlag081-B63","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1093\/jac\/dkae375","article-title":"Therapeutic drug monitoring (TDM) of \u03b2-lactam\/\u03b2-lactamase inhibitor (BL\/BLI) drug combinations: insights from a pharmacometric simulation study","volume":"80","author":"O\u2019Jeanson","year":"2025","journal-title":"J Antimicrob Chemother"},{"key":"2026060405421984900_dlag081-B64","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/nrmicro3432","article-title":"Urinary tract infections: epidemiology, mechanisms of infection and treatment options","volume":"13","author":"Flores-Mireles","year":"2015","journal-title":"Nat Rev Microbiol"},{"key":"2026060405421984900_dlag081-B65","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/life14050614","article-title":"Imipenem\/cilastatin\/relebactam for complicated infections: a real-world evidence","volume":"14","author":"Sansone","year":"2024","journal-title":"Life"},{"key":"2026060405421984900_dlag081-B66","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1177\/10283153241262460","article-title":"Comparing the learning ecologies of international students in internationalisation abroad and at a distance","volume":"29","author":"Huang","year":"2024","journal-title":"J Stud Int Educ"},{"key":"2026060405421984900_dlag081-B67","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fphar.2021.658095","article-title":"Levofloxacin versus ciprofloxacin in the treatment of urinary tract infections: evidence-based analysis","volume":"12","author":"Cao","year":"2021","journal-title":"Front Pharmacol"},{"key":"2026060405421984900_dlag081-B68","doi-asserted-by":"publisher","first-page":"9765","DOI":"10.21037\/apm-21-2042","article-title":"A systematic review and meta-analysis of levofloxacin and ciprofloxacin in the treatment of urinary tract infection","volume":"10","author":"Xue","year":"2021","journal-title":"Ann Palliat Med"},{"key":"2026060405421984900_dlag081-B69","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/AAC.02165-18","article-title":"A systematic review of single-dose aminoglycoside therapy for urinary tract infection: is it time to resurrect an old strategy?","volume":"63","author":"Goodlet","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"2026060405421984900_dlag081-B70","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1093\/cid\/ciu213","article-title":"Colistin and polymyxin B: peas in a pod, or chalk and cheese?","volume":"59","author":"Nation","year":"2014","journal-title":"Clin Infect Dis"},{"key":"2026060405421984900_dlag081-B71","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12879-021-06229-x","article-title":"Burden of illness in US hospitals due to carbapenem-resistant gram-negative urinary tract infections in patients with or without bacteraemia","volume":"21","author":"Shields","year":"2021","journal-title":"BMC Infect Dis"},{"key":"2026060405421984900_dlag081-B72","doi-asserted-by":"publisher","first-page":"555","DOI":"10.2147\/IDR.S187360","article-title":"Clinical evaluation of meropenem-vaborbactam combination for the treatment of urinary tract infection: evidence to date","volume":"16","author":"Herald","year":"2023","journal-title":"Infect Drug Resist"},{"key":"2026060405421984900_dlag081-B73","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fphar.2022.896971","article-title":"Cefiderocol for the treatment of multidrug-resistant gram-negative bacteria: a systematic review of currently available evidence","volume":"13","author":"Wang","year":"2022","journal-title":"Front Pharmacol"},{"key":"2026060405421984900_dlag081-B74","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/microorganisms9102104","article-title":"Virulence potential and treatment options of multidrug-resistant (Mdr) Acinetobacter baumannii","volume":"9","author":"Kumar","year":"2021","journal-title":"Microorganisms"},{"key":"2026060405421984900_dlag081-B75","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1093\/infdis\/jiae233","article-title":"Antibiotic resistance of urinary tract infection recurrences in a large integrated US healthcare system","volume":"230","author":"Ku","year":"2024","journal-title":"J Infect Dis"},{"key":"2026060405421984900_dlag081-B76","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/molecules26092671","article-title":"New antibiotics for multidrug-resistant bacterial strains: latest research developments and future perspectives","volume":"26","author":"Terreni","year":"2021","journal-title":"Molecules"},{"key":"2026060405421984900_dlag081-B77","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1080\/16878507.2020.1730579","article-title":"Assessment of multidrug resistance in bacterial isolates from urinary tract-infected patients","volume":"13","author":"Khan","year":"2020","journal-title":"J Radiat Res Appl Sci"},{"key":"2026060405421984900_dlag081-B78","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1093\/cid\/ciac704","article-title":"Sulopenem for the treatment of complicated urinary tract infections including pyelonephritis: a phase 3, randomized trial","volume":"76","author":"Dunne","year":"2023","journal-title":"Clin Infect Dis"},{"key":"2026060405421984900_dlag081-B79","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1128\/AAC.00603-19","article-title":"Pharmacodynamics of tebipenem: new options for oral treatment of multidrug-resistant gram-negative infections","volume":"63","author":"McEntee","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"2026060405421984900_dlag081-B80","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1017\/ice.2023.137","article-title":"Strategies to prevent catheter-associated urinary tract infections in acute-care hospitals: 2022 update","volume":"44","author":"Patel","year":"2023","journal-title":"Infect Control Hosp Epidemiol"},{"key":"2026060405421984900_dlag081-B81","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/aac.00663-23","article-title":"Case commentary: successful use of cefepime\/zidebactam (WCK 5222) as a salvage therapy for the treatment of disseminated extensively drug-resistant New Delhi metallo-b-lactamase-producing Pseudomonas aeruginosa infection in an adult patient with acute T-cell leukemia","volume":"67","author":"Egge","year":"2023","journal-title":"Antimicrob Agents Chemother"},{"key":"2026060405421984900_dlag081-B82","doi-asserted-by":"publisher","first-page":"A4","DOI":"10.1176\/appi.neuropsych.19020036","article-title":"Moral injury and PTSD: often co-occurring yet mechanistically different","volume":"31","author":"Barnes","year":"2019","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"2026060405421984900_dlag081-B83","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.eururo.2024.03.035","article-title":"European association of urology guidelines on urological infections: summary of the 2024 guidelines","volume":"86","author":"Kranz","year":"2024","journal-title":"Eur Urol"},{"key":"2026060405421984900_dlag081-B84","doi-asserted-by":"publisher","first-page":"e83","DOI":"10.1093\/cid\/ciy1121","article-title":"Clinical practice guideline for the management of asymptomatic bacteriuria: 2019 update by the Infectious Diseases Society of America","volume":"68","author":"Nicolle","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2026060405421984900_dlag081-B85","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1093\/cid\/ciy1054","article-title":"Seven versus 14 days of antibiotic therapy for uncomplicated gram-negative bacteremia: a noninferiority randomized controlled trial","volume":"69","author":"Yahav","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2026060405421984900_dlag081-B86","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1001\/jamainternmed.2018.6226","article-title":"Association of 30-day mortality with oral step-down vs continued intravenous therapy in patients hospitalized with Enterobacteriaceae bacteremia","volume":"179","author":"Tamma","year":"2019","journal-title":"JAMA Intern Med"},{"key":"2026060405421984900_dlag081-B87","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/jcm13123550","article-title":"The efficacy of CO2 vaginal laser in the treatment of recurrent, post-coital and interstitial cystitis: a multicentric prospective study","volume":"13","author":"Luvero","year":"2024","journal-title":"J Clin Med"},{"key":"2026060405421984900_dlag081-B88","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.jcgg.2010.10.008","article-title":"What is the evidence for the role of oestrogen in the prevention of recurrent urinary tract infections in postmenopausal women? An evidence-based review","volume":"1","author":"Leckie","year":"2010","journal-title":"J Clin Gerontol Geriatr"},{"key":"2026060405421984900_dlag081-B89","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1093\/cid\/ciad766","article-title":"Effectiveness of prophylactic oral and\/or vaginal probiotic supplementation in the prevention of recurrent urinary tract infections: a randomized, double-blind, placebo-controlled trial","volume":"78","author":"Gupta","year":"2024","journal-title":"Clin Infect Dis"},{"key":"2026060405421984900_dlag081-B90","doi-asserted-by":"publisher","first-page":"377","DOI":"10.5152\/tud.2018.48742","article-title":"The role of probiotics in women with recurrent urinary tract infections","volume":"44","author":"Akg\u00fcl","year":"2018","journal-title":"Turk J Urol"},{"key":"2026060405421984900_dlag081-B91","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1016\/j.euf.2024.07.002","article-title":"Cranberry juice, cranberry tablets, or liquid therapies for urinary tract infection: a systematic review and network meta-analysis","volume":"10","author":"Moro","year":"2024","journal-title":"Eur Urol Focus"},{"key":"2026060405421984900_dlag081-B92","doi-asserted-by":"publisher","first-page":"498","DOI":"10.3945\/an.115.011197","article-title":"Cranberries and urinary tract infections: how can the same evidence lead to conflicting advice?","volume":"7","author":"Liska","year":"2016","journal-title":"Adv Nutr"},{"key":"2026060405421984900_dlag081-B93","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12937-022-00769-x","article-title":"Role of D-mannose in urinary tract infections\u2014a narrative review","volume":"21","author":"Ala-Jaakkola","year":"2022","journal-title":"Nutr J"},{"key":"2026060405421984900_dlag081-B94","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1001\/jamainternmed.2024.0264","article-title":"D-mannose for prevention of recurrent urinary tract infection among women: a randomized clinical trial","volume":"184","author":"Hayward","year":"2024","journal-title":"JAMA Intern Med"},{"key":"2026060405421984900_dlag081-B95","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1007\/s00120-023-02136-y","article-title":"D-mannose for preventing and treating urinary tract infections. A commentary","volume":"62","author":"Cooper","year":"2023","journal-title":"Die Urologie"},{"key":"2026060405421984900_dlag081-B96","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s12894-025-01708-8","article-title":"Effectiveness of methenamine hippurate in preventing urinary tract infections: an updated systematic review, meta-analysis and trial sequential analysis of randomized controlled trials","volume":"25","author":"Hobaica","year":"2025","journal-title":"BMC Urol"},{"key":"2026060405421984900_dlag081-B97","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1097\/MOU.0000000000001108","article-title":"The resurgence of methenamine hippurate in the prevention of recurrent UTIs in women-a systematic review","volume":"33","author":"Kale","year":"2023","journal-title":"Curr Opin Urol"},{"key":"2026060405421984900_dlag081-B98","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1016\/j.cmi.2025.07.006","article-title":"Methenamine hippurate as prophylaxis for recurrent urinary tract infections in older women\u2013a triple-blind, randomised, placebo-controlled, phase IV trial (ImpresU)","volume":"31","author":"Heltveit-Olsen","year":"2025","journal-title":"Clin Microbiol Infect"},{"key":"2026060405421984900_dlag081-B99","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1097\/us9.0000000000000016","article-title":"Glycosaminoglycan replacement therapy in preventing women\u2019s recurrent urinary tract infections? A systematic review and meta-analysis","volume":"35","author":"Chang","year":"2024","journal-title":"Urol Sci"},{"key":"2026060405421984900_dlag081-B100","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fcimb.2021.656496","article-title":"Nanoparticles as potential novel therapies for urinary tract infections.","volume":"11","author":"S\u00e1nchez","year":"2021","journal-title":"Front Cell Infect Microbiol"},{"key":"2026060405421984900_dlag081-B101","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/nano11020546","article-title":"Nanomaterials for the diagnosis and treatment of urinary tract infections","volume":"11","author":"Qindeel","year":"2021","journal-title":"Nanomaterials"},{"key":"2026060405421984900_dlag081-B102","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1016\/j.euf.2024.07.006","article-title":"Innovations in phage therapy for urinary tract infection","volume":"10","author":"Leitner","year":"2024","journal-title":"Eur Urol Focus"},{"key":"2026060405421984900_dlag081-B103","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fmicb.2016.00465","article-title":"Bacteriophages as potential treatment for urinary tract infections","volume":"7","author":"Sybesma","year":"2016","journal-title":"Front Microbiol"},{"key":"2026060405421984900_dlag081-B104","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fmicb.2025.1512119","article-title":"Predatory bacteria can intensify lung-injury in a multidrug-resistant Acinetobacter baumannii pneumonia model in rat","volume":"16","author":"Mohsenipour","year":"2025","journal-title":"Front Microbiol"},{"key":"2026060405421984900_dlag081-B105","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.1038\/s41598-017-02041-3","article-title":"Examining the efficacy of intravenous administration of predatory bacteria in rats","volume":"7","author":"Shatzkes","year":"2017","journal-title":"Sci Rep"},{"key":"2026060405421984900_dlag081-B106","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1016\/j.euf.2024.08.010","article-title":"Discovery of antimicrobial peptides in urinary tract infections","volume":"10","author":"Voss","year":"2024","journal-title":"Eur Urol Focus"},{"key":"2026060405421984900_dlag081-B107","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1038\/ki.2012.467","article-title":"The antibacterial shield of the human urinary tract","volume":"83","author":"Zasloff","year":"2013","journal-title":"Kidney Int"},{"key":"2026060405421984900_dlag081-B108","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1038\/ki.2012.410","article-title":"Ribonuclease 7, an antimicrobial peptide upregulated during infection, contributes to microbial defense of the human urinary tract","volume":"83","author":"Spencer","year":"2013","journal-title":"Kidney Int"},{"key":"2026060405421984900_dlag081-B109","doi-asserted-by":"publisher","first-page":"2714","DOI":"10.3390\/microorganisms13122714","article-title":"Current scientific advances in vaccines against UTIs: challenges and prospects","volume":"13","author":"Wang","year":"2025","journal-title":"Microorganisms"}],"container-title":["JAC-Antimicrobial Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jacamr\/article-pdf\/8\/3\/dlag081\/68349935\/dlag081.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jacamr\/article-pdf\/8\/3\/dlag081\/68349935\/dlag081.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T09:42:28Z","timestamp":1780566148000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jacamr\/article\/doi\/10.1093\/jacamr\/dlag081\/8688669"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,30]]},"references-count":109,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,4,30]]}},"URL":"https:\/\/doi.org\/10.1093\/jacamr\/dlag081","relation":{},"ISSN":["2632-1823"],"issn-type":[{"value":"2632-1823","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,6]]},"published":{"date-parts":[[2026,4,30]]},"article-number":"dlag081"}}